FDA issues guidance on non-invasive monitoring devices

The Food and Drug Administration Friday released new guidance that expands for the duration of the COVID-19 emergency the availability and capability of non-invasive monitoring devices. This replaces guidance issued March 20, and includes additional device types and offers more references and standards. FDA said remote devices reduce patient and health care provider contact, ultimately limiting possible COVID-19 exposure.